Looks like the NIH's Preclinical Screening Program for Pain (PSPP) has been good to us, all paid for by NIH as well.
Emyria is able to strategically select target indications based on clinical insights within its proprietary Real-World Data set on more than 9,000 patients
Boom! 10K soon great growth on the RWD set feels like only yesterday we were at 5,000 then 8,000.
- Forums
- ASX - By Stock
- Ann: Emyria Unveils Highest Potency CBD Capsule for FDA Pathway
EMD
emyria limited
Add to My Watchlist
3.45%
!
2.8¢

Looks like the NIH's Preclinical Screening Program for Pain...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.8¢ |
Change
-0.001(3.45%) |
Mkt cap ! $17.12M |
Open | High | Low | Value | Volume |
2.8¢ | 2.9¢ | 2.7¢ | $53.84K | 1.904M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 13532 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 907104 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 13532 | 0.028 |
5 | 660506 | 0.027 |
4 | 91557 | 0.026 |
3 | 540000 | 0.025 |
6 | 979393 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 907104 | 4 |
0.031 | 94812 | 1 |
0.032 | 92000 | 1 |
0.034 | 116570 | 2 |
0.035 | 159700 | 3 |
Last trade - 15.57pm 14/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |